SE8604884L - Human mangansuperoxiddismutas-cdna - Google Patents

Human mangansuperoxiddismutas-cdna

Info

Publication number
SE8604884L
SE8604884L SE8604884A SE8604884A SE8604884L SE 8604884 L SE8604884 L SE 8604884L SE 8604884 A SE8604884 A SE 8604884A SE 8604884 A SE8604884 A SE 8604884A SE 8604884 L SE8604884 L SE 8604884L
Authority
SE
Sweden
Prior art keywords
human
superoxide dismutase
dismutase
medium
human manganese
Prior art date
Application number
SE8604884A
Other languages
English (en)
Swedish (sv)
Other versions
SE8604884D0 (sv
Inventor
J R Hartman
Y Beck
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of SE8604884D0 publication Critical patent/SE8604884D0/xx
Publication of SE8604884L publication Critical patent/SE8604884L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8604884A 1985-11-22 1986-11-14 Human mangansuperoxiddismutas-cdna SE8604884L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US90705186A 1986-09-12 1986-09-12

Publications (2)

Publication Number Publication Date
SE8604884D0 SE8604884D0 (sv) 1986-11-14
SE8604884L true SE8604884L (sv) 1987-05-23

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604884A SE8604884L (sv) 1985-11-22 1986-11-14 Human mangansuperoxiddismutas-cdna

Country Status (21)

Country Link
JP (2) JP2609449B2 (enrdf_load_stackoverflow)
AT (1) AT400443B (enrdf_load_stackoverflow)
AU (1) AU607897B2 (enrdf_load_stackoverflow)
BE (1) BE905796A (enrdf_load_stackoverflow)
CA (1) CA1341362C (enrdf_load_stackoverflow)
CH (1) CH676990A5 (enrdf_load_stackoverflow)
DE (1) DE3639725C2 (enrdf_load_stackoverflow)
DK (1) DK534686A (enrdf_load_stackoverflow)
ES (1) ES2003518A6 (enrdf_load_stackoverflow)
FI (1) FI90353C (enrdf_load_stackoverflow)
FR (1) FR2590591B1 (enrdf_load_stackoverflow)
GB (1) GB2183658B (enrdf_load_stackoverflow)
GR (1) GR862713B (enrdf_load_stackoverflow)
HK (1) HK75195A (enrdf_load_stackoverflow)
IE (1) IE59498B1 (enrdf_load_stackoverflow)
IL (2) IL80702A0 (enrdf_load_stackoverflow)
IT (1) IT1205418B (enrdf_load_stackoverflow)
LU (1) LU86676A1 (enrdf_load_stackoverflow)
NL (1) NL8602960A (enrdf_load_stackoverflow)
PT (1) PT83792B (enrdf_load_stackoverflow)
SE (1) SE8604884L (enrdf_load_stackoverflow)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610520B1 (en) * 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
JPH0643341B2 (ja) * 1986-03-27 1994-06-08 宇部興産株式会社 臓器機能改善剤
JPH0643340B2 (ja) * 1986-09-03 1994-06-08 宇部興産株式会社 虚血性心疾患治療薬
JPS6377822A (ja) * 1986-09-18 1988-04-08 Ube Ind Ltd 臓器機能改善剤
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
ATE132902T1 (de) * 1987-03-14 1996-01-15 Boehringer Ingelheim Int Humane mangan-superoxiddismutase (hmn-sod)
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
EP0284105B1 (en) * 1987-03-27 1995-11-15 Bio-Technology General Corporation Human manganese superoxide dismutase and methods of treatment
JPH01233228A (ja) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd 悪性腫瘍細胞転移防止剤
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
DE59310242D1 (de) * 1992-09-09 2002-01-17 Bio Technology General Corp Verwendung von Mangan-Superoxiddismutase (Mn-SOD) zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen in niedriger Dosierung
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (bg) * 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
DE3485284D1 (de) * 1983-10-03 1992-01-02 Chiron Corp Klonieren von superoxid-dismutase und expression in mikroorganismen.

Also Published As

Publication number Publication date
GB2183658A (en) 1987-06-10
DE3639725C2 (de) 1998-02-19
CH676990A5 (enrdf_load_stackoverflow) 1991-03-28
FI90353B (fi) 1993-10-15
IT1205418B (it) 1989-03-15
FR2590591B1 (fr) 1989-12-01
DK534686A (da) 1987-05-23
FI864756A7 (fi) 1987-05-23
JPH08289792A (ja) 1996-11-05
NL8602960A (nl) 1987-06-16
AT400443B (de) 1995-12-27
FI864756A0 (fi) 1986-11-21
PT83792A (en) 1986-12-01
IL80702A0 (en) 1987-02-27
LU86676A1 (fr) 1987-05-04
IT8667865A0 (it) 1986-11-21
AU607897B2 (en) 1991-03-21
HK75195A (en) 1995-05-26
ATA308986A (de) 1995-05-15
GB2183658B (en) 1990-04-25
FI90353C (fi) 1994-01-25
BE905796A (fr) 1987-03-16
JP2967557B2 (ja) 1999-10-25
IL106449A0 (en) 1993-11-15
IL106449A (en) 1997-02-18
IE862851L (en) 1987-05-22
GR862713B (en) 1987-03-24
DE3639725A1 (de) 1987-07-23
AU6497586A (en) 1987-05-28
PT83792B (pt) 1989-01-17
JPS62289187A (ja) 1987-12-16
FR2590591A1 (fr) 1987-05-29
JP2609449B2 (ja) 1997-05-14
DK534686D0 (da) 1986-11-07
GB8627294D0 (en) 1986-12-17
CA1341362C (en) 2002-05-28
SE8604884D0 (sv) 1986-11-14
IE59498B1 (en) 1994-03-09
ES2003518A6 (es) 1988-11-01

Similar Documents

Publication Publication Date Title
SE8604884L (sv) Human mangansuperoxiddismutas-cdna
ATE69466T1 (de) Superoxyddismutase.
DE602004028803D1 (de) Vorläuferzellen aus der wharton sulze von humanen nabelschnüren
DE3066356D1 (en) Process for recovering enzymes from blood
AU2155795A (en) Alphavirus cdna vectors
EP0663921A4 (en) METHOD FOR INCREASING EXPRESSION AND REDUCING EXPRESSION VARIABILITY OF FOREIGN GENES IN PLANT CELLS.
KR850003735A (ko) 인터페론의 제조방법
FR2599625B1 (fr) Procede de production d'activateur du plasminogene biologiquement actif
Kilańczyk et al. The effect of melatonin on antioxidant enzymes in human diabetic skin fibroblasts
ES8403524A1 (es) Un procedimiento para obtener s-adenosil-metionina.
DE68920685D1 (de) Herstellung von Melanin.
DE60035515D1 (de) Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit
DE69027466D1 (de) Achromobacter-Protease-I-Gen sowie Genprodukt
US3490995A (en) Process for the biosynthesis of cellbound pullulanase by aerobacter aerogenes
Gimmler et al. On the mechanism of benzoquinone penetration and photoreduction by whole cells
KR890701733A (ko) 신규 인체 조직형 플리스미노겐 활성제 변이체
JPS6474987A (en) Novel proline acylase and its production
DK0759088T3 (da) L-ascorbinsyreproduktion i mikroorganismer
Cope et al. The effects of interactions between sodium ascorbate and superoxide radicals generated by hypoxanthine and xanthine oxidase on 3T3 cells
JPS6467196A (en) Production of hyaluronic acid and strain used therefor
Hudock et al. Alternative forms of triosephosphate dehydrogenase in Chromatium
DE69316352D1 (de) Eine methode zur einschränkung des uberlebens gentechnologisch hergestellter mikroorganismen in ihrer umgebung
NZ230856A (en) Production of human tissue type plasminogen activator (tpa) under conditions of increased osmotic pressure
JPS6427472A (en) Production of human tissue plasminogen activator and cell strain using therein
JPS5495795A (en) Production of interferon

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8604884-0